Results for tag: "Immunology Partnering"

The Immunology Partnering market is a subset of the larger Immune Disorders Drugs market. It is composed of companies that specialize in the development of treatments for immune-related diseases. These treatments can range from small molecules to biologics, such as monoclonal antibodies, vaccines, and gene therapies. Companies in this market collaborate with each other to develop and commercialize these treatments. The Immunology Partnering market is driven by the increasing prevalence of immune-related diseases, such as autoimmune diseases, allergies, and cancer. This has led to an increased demand for treatments that can effectively address these conditions. Additionally, advances in technology have enabled the development of more effective treatments. Some companies in the Immunology Partnering market include AbbVie, Amgen, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. Show Less Read more